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This paper describes the purification of a 47 kDa protein from Xenopus laevis oocytes that becomes phosphorylated when 
the oocytes undergo meiotic maturation. This protein (p47) is part of a high molecular mass complex containing at least 
two other proteins of molecular mass 30 and 36 kDa. This complex can be isolated from stage VI oocytes before matura- 
tion. We obtained a pattern for phosphopeptides inp47 phosphorylated in vivo very similar to that of the purified protein 
phosphorylated in vitro by ~34~ (a HI kinase which is a component of the M-phase promoting factor) and [y-3ZP]ATP. 
Therefore, the purified p47, already described as a marker of MPF activity, is the first reported in vivo substrate for 
the cell division control kinase. 
Protamine kinase; Meiosis; Promoting factor, M-phase 
1. INTRODUCTION 
Full-grown oocytes from Xenopus laevis are 
naturally arrested at the very end of G2 phase. 
Upon hormonal stimulation they enter M phase 
and mature into metaphase-arrested fertilizable 
eggs. A cytoplasmic factor called MPF (matura- 
tion promoting factor) has been demonstrated by 
transfer experiments to be responsible for the 
maturation of Xenopus oocytes: cytoplasm taken 
from maturing oocytes induces resumption of 
meiosis when microinjected into unstimulated 
prophase-arrested oocytes [l]. MPF has been 
detected in meiotic and mitotic cells from a 
number of species ranging from yeast to man, be- 
ing high in M phase and undetectable in inter- 
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phase. MPF is therefore considered as a 
fundamental regulator of M phase in eukaryotes 
12~31. 
MPF has recently been published using unfer- 
tilized oocytes from Xenopus. It is composed of 
two major proteins, p34 possessing Hl-kinase ac- 
tivity and identified as the product of the homolog 
of the yeast cdc2 gene, and ~45, in vitro, a 
substrate of the p34 kinase [4-81. 
At the time of MPF appearance, a burst in 
CAMP-independent phosphorylation is observed 
[9,10]. Among the numerous phosphorylated pro- 
teins detected at that time, we previously 
characterized a protein, ~47, which had been 
phosphorylated on alkali-resistant threonine 
residues [ 111. The appearance of this phosphopro- 
tein is highly correlated to that of MPF [12]. Our 
intention therefore was to purify p47 and to in- 
vestigate its relation with MPF. 
Here, we describe the purification of p47 and 
demonstrate that it is a substrate for ~34~~~~ 
mitotic kinase in vitro and in vivo. 
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2. MATERIALS AND METHODS 
2.1. Materials 
X. laevis adult females were obtained from Serea-CNRS 
(France) and maintained under laboratory conditions. [32P]Or- 
thophosphate (carrier-free, 10 mCi/ml) and adenosine 
5 ‘-[y-“Pltriphosphate (3000 Ci/mmol) were from Amersham 
(France); hydroxyapatite gel from Bio-Rad; other gels for 
chromatography from Pharmacia (France); histone Hl from 
Boehringer Mannheim; mixed casein, catalytic subunit of 
CAMP-dependent protein kinase (A-kinase) and Staphylococ- 
cus aureus (strain V8) protease from Sigma; pancreatic (Y- 
chymotrypsin from Calbiochem. Casein kinase II was purified 
from X. laevis ovary as described 1131 and ~34’~” (Pll 
phosphocellulose fraction) was prepared from starfish eggs [7]. 
2.2. Preparation and labelling of oocytes 
Defolliculated full-grown oocytes were isolated as in [14]. 
Labelling was performed by incubating oocytes (usually 1000 
oocytes/ml) for one night at room temperature with gentle 
shaking in medium A containing [32P]orthophosphate 
(0.5 mCi/ml). Oocytes were then washed four times with 
medium A. To obtain maturing labelled oocytes, 1 PM pro- 
gesterone was added to the incubation medium 2 h after the 
radioactivity. Maturation was judged according to the presence 
of the white maturation spot on the animal pole of the oocyte. 
2.3. p47 purification 
Oocytes were transferred to 1 vol. ice-cold homogenization 
medium B (75 mM KCI, 50 mM NaF, 10 mM NasHPO+ 1 mM 
EDTA, 10 mM ATP, 100,uM orthovanadate, 5 mM 4-nitro- 
phenyl phosphate, 1.14 mM PhMeSOsF, 0.3 mM L-l-tosyl- 
phenylalanylchloromethane (TosPheCHsCl), 0.3 mM (Y-N- 
benzoyl-L-arginine methyl ester (BzArgOMe), 5 pM soybean 
trypsin inhibitor, 1 mM benzamidine, 0.04 IU/ml aprotinin, 
50 mM Tris; pH 7.4). They were homogenized with five manual 
strokes of a Potter-Elvehjem homogenizer. Vitellin platelets 
and melanosomes were discarded by centrifugation for 5 min at 
800 x g followed by 15 min at 2000 x g at 4°C. The cytosol 
fraction was then obtained by centrifugation (16 min, 130000 x
g) in a Beckman TLlOO ultracentrifuge. When labelled oocytes 
were processed, the bulk of free and lipid-bound radioactivity 
was discarded by rapid filtration of the cytosol fraction on a 
Sephadex G-25 column equilibrated with medium C (1 mM DL- 
dithiothreitol, 2 mM EDTA, 50 mM Tris; pH 7.4). 
A 40-50% (NH&S04 fraction was then prepared at 4°C as 
follows: the cytosol fraction was adjusted to 40% (N&)sS04 by 
adding 243 mg/ml solid ammonium sulfate, incubated for 
60 min and then centrifuged for 15 min at 2000 x g. The pellet 
was discarded and the supernatant brought to 50% (NH&S04 
by addition of 63 mg/ml solid ammonium sulfate. After 60 min 
incubation the fraction was centrifuged (2000 x g, 15 min) and 
the supernatant discarded. The pellet, corresponding to the 
40-50% fraction, was dissolved in 10 ml medium C. 
All chromatography steps were performed in medium C. The 
40-50% fraction was applied to a hydroxyapatite column 
(1.5 x 5.0 cm). After washing, elution was performed with 
40 ml medium C containing 0.5 M potassium phosphate. The 
p47containing fraction was dialysed overnight vs medium C 
and loaded onto a MonoQ HR 5/5 column, a continuous gra- 
dient (40 ml) to 700 mM NaCl in medium C being applied to 
220 
elute proteins. Further purification of p47 was achieved by ap- 
plying the MonoQ fraction (diluted 3 times with medium C) to 
a heparin-Sepharose column (1.0 x 2.5 cm), with elution by a 
continuous gradient (10 ml) to 1 M NaCl in medium C. 
The protein content of fractions was determined by the 
method of Bradford [15]. 
2.4. In vitro phosphorylation of p47 
Incubations were performed at room temperature with gentle 
shaking in 50 ~1 containing 5 pg ~47, 50 mM Hepes (pH 7.4), 
5 mM pNPP, 5 mM MgClz, 10 pM [y-32P]ATP (spec. act. 
-2 pCi/nmol) and 50 IU catalytic subunit of A-kinase (Sigma). 
5 U CKII [13] or 1.25 ~1 ~34~~~’ (standard activity: 
300 pmol/min per rl [7]). After 20 min, 25 ~1 electrophoresis 
buffer were added to the incubation mixture which was then im- 
mediately boiled and analysed on SDS-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) as described below. 
2.5. HI-kinase activity of p3edc2 
To assay Hl-kinase activity, 25 nl ~34’~‘~ was incubated in 
50~1 medium containing 10 ag histone Hl, 5 mM MgC12, 
10 PM [y-“P]ATP (spec. act. -4 ,&i/nmol), 5 mM pNPP and 
50 mM Hepes (pH 7.4) in the presence or absence of 0.5 pg p47 
heparin fraction from prophase or progesterone-matured 
oocytes. After 20 min, 25 ~1 of each incubation mixture were 
spotted onto pieces of P81 phosphocellulose paper, which were 
washed as in [16], and the radioactivity was determined by 
Cerenkov counting in 10 ml water. 
2.6. Electrophoresis, phosphoamino acid analysis and peptide 
mapping 
Proteins were analysed by SDS-PAGE on slabs according to 
[17], using 12% polyacrylamide separation gel. Alkali treat- 
ment of gels and phosphoamino acid analysis were performed 
as described [13]. The procedure of Cleveland et al. [18] for par- 
tial hydrolysis of proteins in gel slices was used for peptide map- 
ping, in the presence of Staphylococcus aureus V8 protease or 
cu-chymotrypsin using 4,4g enzyme per line. 
Radioactive proteins and peptides were detected by exposure 
of gels to Kodak X-AR film at 20°C (untreated gel) or at 
- 80°C (alkali-treated gel) in the presence of an intensifying 
screen. Quantitative analysis was performed by densitometric 
scanning of the autoradiographs with a Shimadzu scanner. 
3. RESULTS 
3.1. Purification of p47 
The distinguishing feature of p47 is the alkali 
resistance of its phosphorylation which occurs 
when MPF is present in oocytes. We therefore 
studied the purification of p47 from progesterone- 
matured oocytes whose phosphoproteins were 
labelled. 1000 oocytes were incubated in the 
presence of “P, induced to mature by 1 ,uM pro- 
gesterone and homogenized at the time of 
metaphase II, in a phosphoprotein-conserving 
medium. Autoradiography of the electrophoretic 
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pattern of the different purification steps is shown 
in fig.lA. The cytosol fraction was prepared by 
centrifugation. p47 was detected in the cytosol 
after SDS-PAGE, alkali treatment of the gel and 
autoradiography as the major alkali-resistant 
phosphoprotein. After rapid gel filtration on 
Sephadex G-25 to eliminate labelled nucleotides, 
lipids and free 32P, the cytosol was fractionated by 
ammonium sulfate precipitation. Alkali-resistant 
p47 was recovered in the 40-50% saturated am- 
monium sulfate fraction. Three chromatographic 
steps were then performed: the p47 eluted at 0.5 M 
potassium phosphate from hydroxyapatite, at 
0.45 M NaCl from MonoQ and at 0.8 M NaCl 
from heparin-Sepharose. The overall purification 
yield was calculated from the total amount 
(estimated by densitometric scanning for NaOH- 
treated gel autoradiography) of alkali-resistant p47 
in the most purified fraction, that of heparin- 
Sepharose, vs that in the initial cytosoluble frac- 
tion as shown in fig.2C; this yield was 5% (SD = 
1.9; n = 4). Radioactivity in protein p47 was 
29.5% (SD = 12.8; n = 7) of the total radioactivity 
in proteins of the heparin fraction. 
When labelled prophase arrested oocytes were 
processed by using the same purification protocol, 
no phosphorylated (alkali-resistant or -susceptible) 
protein with the electrophoretic mobility of p47 
could be detected (fig.lB, upper and lower panels). 
A Coomassie blue-stained band of 47 kDa was 
enriched in the same fractions as those determined 
for alkali-resistant labelled p47 from progesterone- 
matured oocytes. Furthermore, the elution profile 
of the blue band on heparin-Sepharose coincided 
with that of the labelled protein (not shown), 
strongly suggesting that they were the same pro- 
tein. The most highly purified fraction (heparin- 
Sepharose) contained three major stained bands 
(fig.2A): p47 [accounting for 37% (SD = 9, n = 9) 
of proteins in the fraction], and proteins of 30 kDa 
[corresponding to 24% (SD = 6, n = 91 and 36 kDa 
[accounting for 11% (SD = 3, n = 91. The latter 
two are also phosphorylated although less intense- 
ly than p47 (fig.2B). The relative ratio between the 
three bands (~47, ~36, ~30) remained constant dur- 
ing the last three purification steps. When analysed 
by gel filtration on Superose 12 (Pharmacia), all 
proteins contained in the heparin-Sepharose frac- 
tion were recovered in a fraction eluting before 
lipovitellin (350 kDa). These results suggest that 
Fig.1. Autoradiography of 12% SDS-PAGE of the different 
fractions from p47 purification. Fractions (lane): (1) cyto- 
soluble, (2) 40-509’0 ammonium sulfate, (3) hydroxyapatite, (4) 
MonoQ, (5) heparin-Sepharose. (l-3) 10 fig proteins, (4,5) 5 pg 
proteins. Preparation from (A) progesterone-matured and (B) 
prophase oocytes. (Upper) Untreated and (lower) alkali-treated 
gels. 
native p47 exists as a high molecular mass complex 
of greater than 350 kDa. 
Table 1 shows the total protein concentration of 
each fraction prepared from 10000 progesterone- 
matured oocytes from a typical experiment, which 
is representative of the 30 preparations which have 
been made. Based on the amount of the p47 
Coomassie-stained band in the heparin fraction, 
we have calculated that one oocyte contains 
0.43 ,ug ~47, corresponding to 2.6% of the proteins 
in the cytosol fraction. On estimation of the 
specific activity of the intracellular ATP pool after 
“P labelling of oocytes based on the data reported 
in [ 191, we calculated the specific activity of p47 in 
progesterone-matured oocytes to be 1.0 mol 
phosphate/m01 protein. 
When unlabelled prophase arrested oocytes were 
processed according to the purification procedure 
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Fig.2. Electrophoretic pattern of initial (i: cytosol, 30,ug 
proteins) and final (f: heparin fraction, 1Opg proteins) 
purification steps of protein p47 from 2000 progesterone- 
matured oocytes. (A) Coomassie blue-stained gel; (B) 
autoradiography of (A); (C) autoradiography after alkali 
treatment of (A). 
for ~47, the heparin fractions from progesterone- 
matured and prophase oocytes were very similar 
with the same associated proteins (~47, ~30, ~36) 
present in both cases (not shown). 
3.2. Phosporylation of p47 
Incubation of the most highly purified fraction 
of p47 (heparin fraction) in the presence of 
Table 1 
Protein content (in pg) of the different fractions from 
purification of p47 
Fraction Protein content (up) 
Cytosol 163000 
c 50 28000 
HAP 7320 
Mono Q 1760 
Heparin 578 
Protein p47 216 
Protein p36 63 
Protein p30 139 
Proteins were determined as in [IS]. The amounts of p47 and 
p30 in the heparin fraction were determined by densitometric 
integration of the scanned Coomassie-stained gel 
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[Y-~~P]ATP demonstrated the existence of an en- 
dogenous kinase activity in the fraction. The 
amount of kinase activity was variable among dif- 
ferent preparations, indicating that copurification 
of p47 and the kinase was partial. This kinase ac- 
tivity was inhibited by low doses of heparin 
(3 pg/ml), suggesting that it could be a casein 
kinase II type enzyme. This idea was supported by 
the finding that it phosphorylated mixed casein as 
exogenous substrate. The endogenous proteins 
phosphorylated by this kinase were p30 and ~36. 
Purified casein kinase II from Xenopus oocytes 
was also found to be capable of phosphorylating 
p30 and ~36. On the other hand, neither the en- 
dogenous kinase nor purified casein kinase II 
could phosphorylate p47 irrespective of whether it 
had been obtained from prophase-arrested or 
progesterone-matured oocytes. 
We next tested the activity of other purified pro- 
tein kinases for the ability to phosphorylate p47 in 
vitro. Both ~34”~“~ purified from maturing starfish 
oocytes and the catalytic subunit of CAMP- 
dependent protein kinase (A-kinase) were capable 
of phosphorylating p47 purified from stage VI 
oocytes although A-kinase was much less effective. 
Fig.3A shows that p47 prepared from progester- 
one-matured oocytes was only weakly phospho- 
rylated by p34cdc2, the level of labelling 
representing only 10% of that on p47 purified 
from stage VI oocytes. By contrast, phosphoryla- 
tion of p47 from progesterone-matured oocytes by 
A-kinase represented 35% of that for p47 from im- 
mature oocytes. The same result was obtained in 
three independent experiments. We verified that 
the p47 fraction from progesterone-matured 
oocytes contained no inhibitor of ~34~~~~ activity. 
Table 2 shows that he Hl-kinase activity of 
p34cdc2 was unaffected by the presence of p47 in 
the reaction mixture. This experiment was repeated 
twice. We interpret these results to suggest that the 
low degree of phosphorylation of p47 from 
progesterone-matured oocytes by ~34~~~’ was due 
to the site on p47 having already been 
phosphorylated by ~34~~~~ in vivo. 
In order to confirm that the same site was indeed 
phosphorylated in intact cells as that in vitro, we 
performed alkaline hydrolysis on a gel of the pro- 
tein phosphorylated by ~34~~~~ in vitro. As shown 
in fig.3B, the labelled protein was resistant to 
treatment with alkali. By contrast, in vitro 
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Fig.3. Autoradiography of 12% SDS-PAGE analysis of p47 
phosphorylation by p34cdc2. Heparin fractions from prophase 
(P) or progesterone-matured (M) oocytes were phosphorylated 
as indicated in the text. (A) Untreated and (B) alkali-treated 
gels. 
phosphorylation by A-kinase was not alkali- 
resistant (not shown), indicating that the in vivo 
phosphorylation could not be due to A-kinase ac- 
tivity. The alkali resistance of p47 phosphorylated 
in vivo is known to be due to threonine residues 
[l 11. Fig.4 confirms that phosphorylation of p47 
by ~34’~~’ occurred exclusively on threonine 
residues. 
We finally compared peptide maps of p47 
phosphorylated in vivo and in vitro by ~34~~~‘. 
Table 2 
Effect of p47 fraction on in vitro histone kinase activity of 
p34c*cz 
Activity (pmol/min 
per 25 nl enzyme) 
p34c*cZ 0.0% 
p34c*cz + prophase p47 0.0% 
p34c*cZ + matured p47 0.101 
Fig.4. Autoradiography of phosphoamino acid analysis of p47 
protein after (A) in vivo and (B) in vitro phosphorylation by 
p34c*c2. Arrows: authentic phosphoamino acids. 
The kinase activity of ~34~~~’ was determined in the presence of 
purified p47 fractions prepared from prophase and 
progesterone-matured oocytes as described in section 2. Each 
point corresponds to duplicate determinations 
Fig.5. Autoradiography of 15% SDS-PAGE of p47 
phosphopeptides after proteolytic digestion by (A) cy- 
chymotrypsin and (B) V8 protease. Peptide patterns from p47 
phosphorylated: (lane 1) in vitro by ~34~~~’ and (lane 2) in vivo. 
223 
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After partial proteolysis by a-chymotrypsin, the 
labelled peptide patterns obtained from both 
preparations of p47 were identical (fig.SA). A 
similar result was obtained with V8 protease 
(fig.SB). 
4. CONCLUSION 
We have purified a protein, ~47, which is 
phosphorylated in vivo during meiotic maturation 
of Xenopus oocytes. The protein appears to be a 
part of a high molecular mass complex that con- 
tains three major components of 30, 36 and 
47 kDa. The same complex can be purified from 
immature oocytes or progesterone-matured 
oocytes; however, the p47 component is only 
phosphorylated during maturation. 
Multiple protein kinases are activated at the time 
of appearance of MPF [20-221 and any one of 
these activities could account for p47 phosphoryla- 
tion. Our results suggest that p47 is a direct 
substrate for phosphorylation by the ~34~~~’ 
mitotic protein kinase. This is indicated by the 
equal degree of alkali resistance of phosphorylated 
residue(s), the identical peptide pattern obtained 
by partial proteolysis by two different proteases 
and the inability of ~34~~~’ to phosphorylate p47 
prepared from progesterone-matured oocytes. In 
addition, the time course of p47 phosphorylation 
in vivo coincides with activation of ~34~~~’ during 
meiosis [7,12]. Taken together, these data strongly 
support the idea that protein p47 is a direct 
substrate for ~34~~~~ in maturing oocytes. 
As far as we know, p47 is the first reported in 
vivo substrate of the ~34~~~’ kinase. Phosphoryla- 
tion of p47 occurs at the time of numerous changes 
associated with MPF activation. Interestingly, 
analysis of the amino acid sequences of p47 and 
p30 associated protein indicates sequence 
homologies of p30 with elongation factors [23]. 
Accordingly, we are currently investigating the role 
of this complex and its phosphorylation in protein 
synthesis. 
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